Training Experience of Industrial Data Management in Guizhou Province
Release time:
2023-03-04
In the information age, enterprises need to combine their own reasonable situation, make efficient use of advanced information technology, promote enterprise management optimization to strengthen the construction of their own information management system, promote the sustainable and healthy development of enterprises, and accelerate the pace of digital transformation under the epidemic, which also makes relevant enterprises face new challenges. In this context, Huang Ping Jianfeng relied on the scale advantage of the cement industry in the early stage of its construction, took the opportunity of improving basic management, relied on modern information technology tools, and built an intelligent cement production plant with the help of the intelligent integration of "software and hardware Internet AI" , and made the cement production including the central control operating system and various businesses fully realize digital system integration, we have built an information architecture with DCS system, ERP system and MES system as the core and other auxiliary systems as the auxiliary. Since
was put into production in 2020 , Huang Ping Jianfeng has also been continuously exploring digital and intelligent related work. On the basis of realizing economic benefits, it can finally realize an intelligent factory with digital resources and mining environment, intelligent technical equipment, visual production process control, networked information transmission, scientific production management and decision-making. Through learning the excellent cases of Guizhou Xijiu Group, Panjiang Civil Explosion Group and Xingren Denggao New Materials, I have seen and learned the good practices and experiences of other units. Compared with the implementation status of digital and intelligent control in our enterprises, I think Huang Ping Jianfeng still needs to improve and strengthen the digital and intelligent control of factories in many aspects such as system, equipment, procurement, marketing, personnel management, employee skills and safety management.
In the information construction work, there will be a large amount of data generated in each link, although we have relevant information systems as a means of management and analysis, but the concept of data identification and analysis is relatively vague, resulting in our subsequent data management and maintenance is relatively weak. Through two days of study and training, I have a further understanding of the identification principles, identification methods and identification processes of important data and core data in the industrial field. I have a direction and method for the development of enterprise data management work, and have also strengthened the learning of data management capability maturity evaluation model, data security capability maturity model and enterprise big data empowerment. In the subsequent work, I can also evaluate the data management and security capabilities based on the actual situation of the enterprise, and improve the deficiencies in the data management work, which can better escort the digital transformation of the enterprise, and continue to assist and promote the intelligence of the enterprise. The advancement of automation level construction. (Pan Chaochun)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31